Brief: Surface Oncology Inc- Cash Sufficient To Fund Operations Into 2024
03/08/2022 12:00
Aug 3 (Reuters) - Surface Oncology Inc SURF.O :
* CASH SUFFICIENT TO FUND OPERATIONS INTO 2024
* QTRLY NET LOSS PER SHARE BASIC AND DILUTED$0.46
* AS OF JUNE 30, 2022, CASH, CASH EQUIVALENTS, MARKETABLE
SECURITIES WERE $156.6 MILLION
* Q2 EARNINGS PER SHARE VIEW $-0.46 -- REFINITIV IBES DATA
* Q2 EARNINGS PER SHARE VIEW $-0.46 -- REFINITIV IBES DATA
Further company coverage: SURF.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Surface Oncology
See all newsBrief: Surface Oncology Says Anticipates Will Have Net Cash Of $20 Million To $25 Million At The Closing Of The Proposed Mergers
Surface Oncology Inc reports results for the quarter ended in June - Earnings Summary
Brief: Surface Oncology, Inc. Q2 Net Income USD -28.2 Mln
Surface Oncology Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: ADAR1 Partners Reports 5.24% Passive Stake In Surface Oncology Inc As Of July 10 - SEC Filing